In memoriam: Michael J. Chamberlin
Michael J. Chamberlin, an editorial board member of the Journal of Biological Chemistry and a pioneer in the study of transcription, died on November 1 at age 88. He was an ¾«Æ·¹ú²úÒ»Çø¶þÇøÌÒÉ« member for nearly 60 years. He was also an elected member of the National Academy of Sciences and the American Academy of Arts & Sciences.
Born June 7, 1937, in Chicago, Chamberlin received a B.S. in chemistry from Harvard University and a Ph.D. in biochemistry from Stanford University. After earning his Ph.D., Chamberlin joined the University of California, Berkeley, as a professor of biochemistry and molecular biology.
Chamberlin advanced the study of RNA polymerases and transcription regulation. In graduate school, Chamberlin worked with Paul Berg and was the first to isolate RNA polymerase from E. coli.
Chamberlin discovered that RNA polymerases regulate gene activity, a function that was unknown at the time. He showed that transcription begins when RNA polymerase binds to DNA and locates a specific promoter. In 1974, he that led to a model for RNA chain initiation by RNA polymerase.
In 2021, the Stanford Medicine Alumni Association honored Chamberlin with the Arthur Kornberg and Paul Berg Lifetime Achievement Award in Biomedical Sciences.
on Chamberlin’s legacy, , professor of genetics and development at UC Berkeley, said that messenger RNA vaccines “were made possible by the pioneering work (Chamberlin) did on bacteriophage RNA polymerases in the 1970s and 1980s.”
Colleagues described Chamberlin as energized, intense, enthusiastic, magnetic and warm. ASBMB President Joan Conaway described Chamberlin as a valuable informal mentor and friend who helped her and her husband, especially in the earliest stages of their careers.
"Mike was special: a scientist of uncommon rigor and integrity, who helped shape the transcription field and inspired many,” she said.
Chamberlin is survived by his wife, Caroline Kane, a professor in residence emerita at UC Berkeley, and his brothers Peter, Steve and Tom.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

Building the blueprint to block HIV
Wesley Sundquist will present his work on the HIV capsid and revolutionary drug, Lenacapavir, at the ASBMB Annual Meeting, March 7–10, in Maryland.

In memoriam: Alan G. Goodridge
He made pioneering discoveries on lipid metabolism and was an ASBMB member since 1971.

Alrubaye wins research and teaching awards
He was honored at the NACTA 2025 conference for the Educator Award and at the U of A State and National Awards reception for the Faculty Gold Medal.

Designing life’s building blocks with AI
Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.

Jordahl named Gilliam Fellow
He will receive three years of funding to support his thesis research.

Bibel named assistant professor
She began her position at Loyola Marymount University in August 2025.